PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32074497-2	2020	At present, proton-pump inhibitor and amoxicillin-based triple therapy, including clarithromycin (PAC) and metronidazole (PAM), are two commonly used first-line therapies for H. pylori infection, which has a high incidence and possibly poor prognosis worldwide.	Metronidazole	107-120	peptidylglycine alpha-amidating monooxygenase	Homo sapiens	122-125	
10233191-18	1999	Significantly lower cure rates were observed in metronidazole-resistant patients treated with PAM (56% vs. 96%, P = 0.01) or PCM (50% vs. 97%, P = 0.01).	Metronidazole	48-61	peptidylglycine alpha-amidating monooxygenase	Homo sapiens	94-97